Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Several fruits, hardy vegetables, warming spices, and other foods contain anti-inflammatory compounds that help reduce inflammation for better overall health.

The system wasn’t designed with Black people in mind. Elvenia Gray-Sandiford has a plan to change that. A Tyee Q&A.

For the secretive billionaire Besnier family, the recent recall of potentially dangerous infant formula made by its nearly ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...

In 1869, Swiss scientist Friedrich Miescher isolated a mysterious substance from cell nuclei—an overlooked finding that would ...

Eisai Co., Ltd. ("Eisai") and Shanghai Henlius Biotech, Inc. ("Henlius") today announced the conclusion of an exclusive commercialization and ...

Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug development VectoryY Therapeutics, a leader in vectorized antibody therapies ...

From natural colorant to bioactive resource, annatto seeds offer intriguing scientific promise—tempered by clear limits that ...